Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies.
2015
Rouillon, J., J. Poupiot, et al. (2015).
Hum Mol Genet 24(17): 4916-4932.
2015
Rouillon, J., J. Poupiot, et al. (2015).
Hum Mol Genet 24(17): 4916-4932.
